![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Aarti Drugs Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Metformin Hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2005-072 - Rev 00
This Chemical Type CEP, issued on April 09, 2009, remains in force until March 06, 2014, ensuring its reliability within the pharmaceutical industry.
Substance Number 931 associated with this CEP further emphasizes